Canada markets closed

Ionis Pharmaceuticals, Inc. (IONS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
41.74-0.76 (-1.79%)
At close: 04:00PM EDT
42.63 +0.89 (+2.13%)
After hours: 04:27PM EDT
Show:
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
787,647
787,647
587,367
810,456
729,264
Cost of Revenue
9,133
9,133
14,116
10,842
11,947
Gross Profit
778,514
778,514
573,251
799,614
717,317
Operating Expenses
Research Development
899,625
899,625
833,147
643,453
535,077
Selling General and Administrative
232,600
232,600
150,300
170,900
332,200
Total Operating Expenses
1,132,225
1,132,225
983,447
814,353
867,277
Operating Income or Loss
-353,711
-353,711
-410,196
-14,739
-149,960
Interest Expense
75,597
75,597
2,800
4,400
6,200
Total Other Income/Expenses Net
101,222
101,222
160,328
-5,013
24,840
Income Before Tax
-333,965
-333,965
-257,985
-29,148
-134,552
Income Tax Expense
32,321
32,321
11,737
-551
345,191
Income from Continuing Operations
-366,286
-366,286
-269,722
-28,597
-479,743
Net Income
-366,286
-366,286
-269,722
-28,597
-444,263
Net Income available to common shareholders
-366,286
-366,286
-269,722
-28,597
-444,263
Basic EPS
-2.87
-2.56
-1.90
-0.20
-3.18
Diluted EPS
-2.87
-2.56
-1.90
-0.20
-3.18
Basic Average Shares
142,801
143,190
141,848
141,021
139,612
Diluted Average Shares
142,801
143,190
141,848
141,021
139,612